Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
TOT BIOPHARM International Co. Ltd. ( (HK:1875) ) just unveiled an announcement.
BioDlink International Company Limited announced changes in its leadership, with Dr. Liu and Ms. Yeh-Huang resigning from their respective positions due to family reasons. This reshuffling may impact the company’s strategic direction and governance, as it involves key roles such as the executive director, chief executive officer, and members of the Strategy and ESG Committee.
The most recent analyst rating on (HK:1875) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on TOT BIOPHARM International Co. Ltd. stock, see the HK:1875 Stock Forecast page.
More about TOT BIOPHARM International Co. Ltd.
Average Trading Volume: 412,868
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.66B
For detailed information about 1875 stock, go to TipRanks’ Stock Analysis page.